TREE NEWS update: Huang Guo, head of China’s National Medical Products Administration, led a delegation to Lhasa and Shannan in Tibet to study Tibetan medicine development. He called for faster improvement of Tibetan medicine standards, greater use of ancient classic formulas, and conversion of classic formulas and hospital preparations into new drugs, along with protection of medicinal plant resources and standardized cultivation to ensure quality and sustainability.
China’s NMPA Head Huang Guo Visits Tibet to Push Tibetan Medicine Development
AI take
This signals Beijing's intent to formalize Tibetan medicine under national drug standards, which could matter for anyone tracking traditional-medicine supply chains and the botanical raw materials behind them. The push to convert classic formulas and hospital preparations into approved drugs implies a narrower, more regulated pipeline for producers and cultivators in the region. Whether standardized cultivation and resource protection keep pace with that conversion is the open question.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
24m ago
Beijing Stock Exchange Penalizes 3 Investors for Private New-Share Deals
47m ago
China’s NMPA Head Huang Guo Visits Tibet to Promote Tibetan Medicine Development
1h ago
Fed, FDIC Seek Comment on Third-Party Risk Management
1h ago
Chengdu Opens Public Comment on ‘Token Voucher’ Subsidy Scheme
1h ago
Hassett: Trump Would Have Views If Fed Raises Rates
3h ago
China’s CSRC Sets Minimum Registered Capital Rules for Futures Firms